Top Two Hot of the Day: Global Blood Therapeutics, Inc. (NASDAQ:GBT), Mizuho Financial Group, Inc. (NYSE:MFG)

u.s stocks , earnings estimates

Global Blood Therapeutics, Inc. (NASDAQ:GBT)

Global Blood Therapeutics, Inc. (NASDAQ:GBT) closed at $71.71 on the last trading session with an decrease of -4.35%, whereas, it previously closed at $74.97. The company has a market capitalization of $4.38 Billion. The company traded shares of 494225 on the trading day while its three month average volume stands at 1.24 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of Global Blood Therapeutics, Inc. (NASDAQ:GBT) produced diluted EPS of -3.89. The EPS estimate for next year as estimated by analysts is at -4.42 while EPS for next quarter is estimated at -1.24. Earnings per Share growth for this year is reported at -23.2, while the analysts estimated the EPS growth for next year at -4.42% and Earnings growth for next 5 years stands at 37% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at -30.2%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of Global Blood Therapeutics, Inc. (NASDAQ:GBT) is at 0 while the forward p/e is at 0. The P/S or Price to Sales ratio of Global Blood Therapeutics, Inc. (NASDAQ:GBT) stands at 0 and Price to Book or P/B for the most recent quarter stands at 6.55. The Price to Free Cash Flow ratio or P/FCF is reported at 0. The quick ratio and the current ratio of Global Blood Therapeutics, Inc. (NASDAQ:GBT) are reported at 14.9 and 14.9 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Global Blood Therapeutics, Inc. (NASDAQ:GBT) stands at -32.3, -35.3 and 0 respectively

The trailing twelve month Revenue of Global Blood Therapeutics, Inc. (NASDAQ:GBT) is reported at 0 with income of -220000000. The outstanding shares of Global Blood Therapeutics, Inc. (NASDAQ:GBT) are 61.14 Million. The institutional Ownership of the shares of 13.26 stands at 0.80%, this figure is decreased -3.12 in the last six months. The insider ownership for the shares of Global Blood Therapeutics, Inc. (NASDAQ:GBT) is ticked at 2.2%, the figure is plummeted -16.25% in the last six months.

Some other important financial aspects to be discussed here for Global Blood Therapeutics, Inc. (NASDAQ:GBT) is the Mean Target Price estimated by the analysts which stands at 101.44. The 52 week high of Global Blood Therapeutics, Inc. (NASDAQ:GBT) is placed at 87.54 and 52 week low is standing at 44.17.

Performance wise the shares of Global Blood Therapeutics, Inc. (NASDAQ:GBT) rose up 0.14% for the week, it also fell -14.94% for the monthly performance, while for the quarter it went down 48.22%. The shares increase 48.96% for the half year and plummeted for the Year-To-Date performance. The shares of Global Blood Therapeutics, Inc. (NASDAQ:GBT) grew 42.62% for the yearly performance.

Mizuho Financial Group, Inc. (NYSE:MFG)

Mizuho Financial Group, Inc. (NYSE:MFG) closed at $2.93 on the last trading session with an decrease of -0.68%, whereas, it previously closed at $2.95. The company has a market capitalization of $37.15 Billion. The company traded shares of 340069 on the trading day while its three month average volume stands at 248.36 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of Mizuho Financial Group, Inc. (NYSE:MFG) produced diluted EPS of 0.44. The EPS estimate for next year as estimated by analysts is at 0 while EPS for next quarter is estimated at 0. Earnings per Share growth for this year is reported at 0, while the analysts estimated the EPS growth for next year at 0% and Earnings growth for next 5 years stands at 1.8% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at 3.59%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of Mizuho Financial Group, Inc. (NYSE:MFG) is at 6.6 while the forward p/e is at 0. The P/S or Price to Sales ratio of Mizuho Financial Group, Inc. (NYSE:MFG) stands at 0 and Price to Book or P/B for the most recent quarter stands at 0.44. The Price to Free Cash Flow ratio or P/FCF is reported at 0. The quick ratio and the current ratio of Mizuho Financial Group, Inc. (NYSE:MFG) are reported at 0 and 0 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Mizuho Financial Group, Inc. (NYSE:MFG) stands at 0, 0 and 0 respectively

The trailing twelve month Revenue of Mizuho Financial Group, Inc. (NYSE:MFG) is reported at 0 with income of 0. The outstanding shares of Mizuho Financial Group, Inc. (NYSE:MFG) are 12.68 Billion. The institutional Ownership of the shares of 0.47 stands at 0.80%, this figure is increased 0 in the last six months. The insider ownership for the shares of Mizuho Financial Group, Inc. (NYSE:MFG) is ticked at 0%, the figure is rose 0% in the last six months.

Some other important financial aspects to be discussed here for Mizuho Financial Group, Inc. (NYSE:MFG) is the Mean Target Price estimated by the analysts which stands at 3.81. The 52 week high of Mizuho Financial Group, Inc. (NYSE:MFG) is placed at 3.20 and 52 week low is standing at 2.66.

Performance wise the shares of Mizuho Financial Group, Inc. (NYSE:MFG) fell down -2.33% for the week, it also fell -2.66% for the monthly performance, while for the quarter it went up -7.86%. The shares increase 1.38% for the half year and plummeted for the Year-To-Date performance. The shares of Mizuho Financial Group, Inc. (NYSE:MFG) shrinked -5.79% for the yearly performance.